logo
Sign in

SRZNW Stock Price, Chart, Stats & News

Surrozen, Inc.
Save
100,197
Market cap
Current P/E
Forward P/E

SRZNW chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
84.56%
Operating margin
-1210.58%
Pretax margin
-6960.77%
Net margin
-6960.77%
Effective tax rate
ROA
-245.15%
ROE
610.83%
D/E
-0.04x
Interest coverage ratio

SRZNW valuation

P/E
P/S
62.15x
P/B
-1.15x
P/CF
-7.15x
P/FCF
-7.12x
P/OCF
-7.15x
PEG
0.01x
EV multiple
-2.92x

About

Surrozen, Inc. is a biotechnology company dedicated to identifying and advancing therapeutic candidates. Their core strategy involves precisely influencing the Wnt signaling pathway to promote the body's natural processes of tissue restoration and regeneration. To achieve this, Surrozen engineers antibodies that target specific tissues, aiming to activate the intrinsic repair systems of the body.

Similar securities

Based on sector and market capitalization

Report issue